SLC5A2 and Glycosuria: SGLT2 inhibitor-induced glucosuria is proportional to the amount of glucose filtered by the kidneys; therefore, decreased plasma glucose concentration diminishes the action of SGLT2 inhibitors on the kidneys.4,5